Analysis of a total of 962 patients with breast cancer revealed that 0.3% of invasive carcinomas showed loss of Nischarin expression and that 0.7% of invasive carcinomas expressed mutated Nischarin.22 This evidence concerns the gene NISCH and breast carcinoma.